echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Microbiology News > Assaying Interleukins in Plasma in the Course of Acute Myocardial Infarction

    Assaying Interleukins in Plasma in the Course of Acute Myocardial Infarction

    • Last Update: 2021-02-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Acute myocardial infarction (AMI) is one of the most common diseases in cardiology. Recent studies have shown the important role of an activated immune system and its products (interleukins) in the pathogenesis of AMI in these processes:
    1. 
    Ischemia and reperfusion process with immune-mediated myocyte injury and postischemic myocardial inflammation (1 3 ).
    2. 
    Structural and geometric changes in the left ventricle, commonly referred to as remodeling (4 ).
    3. 
    The process of myocyte apoptosis, leading to the loss of myocardial contractile function (5 ).
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.